NCT04577989View on ClinicalTrials.gov

Clinical Comparison of Treatment Strategies in AmpC Beta-lactamase Producing Enterobacterales in a Swiss Tertiary Care Hospital

CompletedOBSERVATIONAL
Enrollment

270

Participants

Timeline

Start Date

December 14, 2020

Primary Completion Date

December 19, 2022

Study Completion Date

December 19, 2022

Conditions
Infection With AmpC Beta-lactamase Producing Enterobacterales
Interventions
OTHER

data collection

data collection for treatment strategies (cefepime vs. piperacillin/tazobactam vs. carbapenems) of infections caused by AmpC beta-lactamase producing Enterobacterales for the period January 1st , 2015 until July 31st , 2020.

Trial Locations (1)

4031

Division of Infectious Disease and Hospital Epidemiology, University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT04577989 - Clinical Comparison of Treatment Strategies in AmpC Beta-lactamase Producing Enterobacterales in a Swiss Tertiary Care Hospital | Biotech Hunter | Biotech Hunter